How big is the noninvasive dna prenatal testing market?

Noninvasive prenatal DNA testing is a new generation of prenatal testing technology that uses nextgeneration highthroughput sequencing to detect fetal chromosomal abnormalities.According to QYResearchs new survey global Noninvasive DNA Prenatal Testing market is projected to reach US 10400 million in 2029 increasing from US 4703 million in 2022 with the CAGR of 12.0 during the period of 2023 to 2029.

Who are the key players in the noninvasive dna prenatal testing market?

Some of the key players are Companies, Thermo Fisher Scientific, Agilent Technologies, Others.

BUY CHAPTERS

Global Non-invasive DNA Prenatal Testing Market Research Report 2023

Code: QYRE-Auto-15M15093

Report

August 2023

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Thermo Fisher Scientific

Pacific Biosciences of California

Non-invasive DNA Prenatal Testing Market Size

According to QYResearch’s new survey, global Non-invasive DNA Prenatal Testing market is projected to reach US$ 10400 million in 2029, increasing from US$ 4703 million in 2022, with the CAGR of 12.0% during the period of 2023 to 2029.

Non-invasive DNA Prenatal Testing Market

Non-invasive prenatal DNA testing is a new generation of prenatal testing technology that uses next-generation high-throughput sequencing to detect fetal chromosomal abnormalities.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-invasive DNA Prenatal Testing market research.

Key companies engaged in the Non-invasive DNA Prenatal Testing industry include Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx and Agilent Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Non-invasive DNA Prenatal Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-invasive DNA Prenatal Testing market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-invasive DNA Prenatal Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Non-invasive DNA Prenatal Testing Market Report

Report Metric	Details
Report Name	Non-invasive DNA Prenatal Testing Market
Accounted market size in 2022	US$ 4703 million
Forecasted market size in 2029	US$ 10400 million
CAGR	12.0%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Equipment Consumables
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx, Agilent Technologies, Labcorp, Mutiplicon, Premaitha Health, Beijing BGI, Berry Genomics, Darui Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Non-invasive DNA Prenatal Testing Market market growing?

Ans: The Non-invasive DNA Prenatal Testing Market market witnessing a CAGR of 12.0% during the forecast period 2023-2029.

What is the Non-invasive DNA Prenatal Testing Market market size in 2029?

Ans: According to QYResearch’s new survey, global Non-invasive DNA Prenatal Testing market is projected to reach US$ 10400 million in 2029, increasing from US$ 4703 million in 2022, with the CAGR of 12.0% during the period of 2023 to 2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-invasive DNA Prenatal Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Equipment

1.2.3 Consumables

1.3 Market by Application

1.3.1 Global Non-invasive DNA Prenatal Testing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-invasive DNA Prenatal Testing Market Perspective (2018-2029)

2.2 Non-invasive DNA Prenatal Testing Growth Trends by Region

2.2.1 Global Non-invasive DNA Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Non-invasive DNA Prenatal Testing Historic Market Size by Region (2018-2023)

2.2.3 Non-invasive DNA Prenatal Testing Forecasted Market Size by Region (2024-2029)

2.3 Non-invasive DNA Prenatal Testing Market Dynamics

2.3.1 Non-invasive DNA Prenatal Testing Industry Trends

2.3.2 Non-invasive DNA Prenatal Testing Market Drivers

2.3.3 Non-invasive DNA Prenatal Testing Market Challenges

2.3.4 Non-invasive DNA Prenatal Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-invasive DNA Prenatal Testing Players by Revenue

3.1.1 Global Top Non-invasive DNA Prenatal Testing Players by Revenue (2018-2023)

3.1.2 Global Non-invasive DNA Prenatal Testing Revenue Market Share by Players (2018-2023)

3.2 Global Non-invasive DNA Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-invasive DNA Prenatal Testing Revenue

3.4 Global Non-invasive DNA Prenatal Testing Market Concentration Ratio

3.4.1 Global Non-invasive DNA Prenatal Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-invasive DNA Prenatal Testing Revenue in 2022

3.5 Non-invasive DNA Prenatal Testing Key Players Head office and Area Served

3.6 Key Players Non-invasive DNA Prenatal Testing Product Solution and Service

3.7 Date of Enter into Non-invasive DNA Prenatal Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive DNA Prenatal Testing Breakdown Data by Type

4.1 Global Non-invasive DNA Prenatal Testing Historic Market Size by Type (2018-2023)

4.2 Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Type (2024-2029)

5 Non-invasive DNA Prenatal Testing Breakdown Data by Application

5.1 Global Non-invasive DNA Prenatal Testing Historic Market Size by Application (2018-2023)

5.2 Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Non-invasive DNA Prenatal Testing Market Size (2018-2029)

6.2 North America Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)

6.4 North America Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-invasive DNA Prenatal Testing Market Size (2018-2029)

7.2 Europe Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)

7.4 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size (2018-2029)

8.2 Asia-Pacific Non-invasive DNA Prenatal Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2018-2023)

8.4 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-invasive DNA Prenatal Testing Market Size (2018-2029)

9.2 Latin America Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)

9.4 Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size (2018-2029)

10.2 Middle East & Africa Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)

10.4 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Detail

11.1.2 Illumina Business Overview

11.1.3 Illumina Non-invasive DNA Prenatal Testing Introduction

11.1.4 Illumina Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.1.5 Illumina Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Non-invasive DNA Prenatal Testing Introduction

11.2.4 Roche Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.2.5 Roche Recent Development

11.3 Natera

11.3.1 Natera Company Detail

11.3.2 Natera Business Overview

11.3.3 Natera Non-invasive DNA Prenatal Testing Introduction

11.3.4 Natera Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.3.5 Natera Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Introduction

11.4.4 Thermo Fisher Scientific Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 F. Hoffman-La Roche

11.5.1 F. Hoffman-La Roche Company Detail

11.5.2 F. Hoffman-La Roche Business Overview

11.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Introduction

11.5.4 F. Hoffman-La Roche Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.5.5 F. Hoffman-La Roche Recent Development

11.6 Pacific Biosciences Of California

11.6.1 Pacific Biosciences Of California Company Detail

11.6.2 Pacific Biosciences Of California Business Overview

11.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Introduction

11.6.4 Pacific Biosciences Of California Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.6.5 Pacific Biosciences Of California Recent Development

11.7 Perkinelmer

11.7.1 Perkinelmer Company Detail

11.7.2 Perkinelmer Business Overview

11.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Introduction

11.7.4 Perkinelmer Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.7.5 Perkinelmer Recent Development

11.8 LifeCodexx

11.8.1 LifeCodexx Company Detail

11.8.2 LifeCodexx Business Overview

11.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Introduction

11.8.4 LifeCodexx Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.8.5 LifeCodexx Recent Development

11.9 Agilent Technologies

11.9.1 Agilent Technologies Company Detail

11.9.2 Agilent Technologies Business Overview

11.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Introduction

11.9.4 Agilent Technologies Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.9.5 Agilent Technologies Recent Development

11.10 Labcorp

11.10.1 Labcorp Company Detail

11.10.2 Labcorp Business Overview

11.10.3 Labcorp Non-invasive DNA Prenatal Testing Introduction

11.10.4 Labcorp Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.10.5 Labcorp Recent Development

11.11 Mutiplicon

11.11.1 Mutiplicon Company Detail

11.11.2 Mutiplicon Business Overview

11.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Introduction

11.11.4 Mutiplicon Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.11.5 Mutiplicon Recent Development

11.12 Premaitha Health

11.12.1 Premaitha Health Company Detail

11.12.2 Premaitha Health Business Overview

11.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Introduction

11.12.4 Premaitha Health Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.12.5 Premaitha Health Recent Development

11.13 Beijing BGI

11.13.1 Beijing BGI Company Detail

11.13.2 Beijing BGI Business Overview

11.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Introduction

11.13.4 Beijing BGI Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.13.5 Beijing BGI Recent Development

11.14 Berry Genomics

11.14.1 Berry Genomics Company Detail

11.14.2 Berry Genomics Business Overview

11.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Introduction

11.14.4 Berry Genomics Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.14.5 Berry Genomics Recent Development

11.15 Darui Biological

11.15.1 Darui Biological Company Detail

11.15.2 Darui Biological Business Overview

11.15.3 Darui Biological Non-invasive DNA Prenatal Testing Introduction

11.15.4 Darui Biological Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)

11.15.5 Darui Biological Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Companies

Thermo Fisher Scientific

Pacific Biosciences of California

List of Tables

Table 1. Global Non-invasive DNA Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Equipment

Table 3. Key Players of Consumables

Table 4. Global Non-invasive DNA Prenatal Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 5. Global Non-invasive DNA Prenatal Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Non-invasive DNA Prenatal Testing Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Non-invasive DNA Prenatal Testing Market Share by Region (2018-2023)

Table 8. Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Non-invasive DNA Prenatal Testing Market Share by Region (2024-2029)

Table 10. Non-invasive DNA Prenatal Testing Market Trends

Table 11. Non-invasive DNA Prenatal Testing Market Drivers

Table 12. Non-invasive DNA Prenatal Testing Market Challenges

Table 13. Non-invasive DNA Prenatal Testing Market Restraints

Table 14. Global Non-invasive DNA Prenatal Testing Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Non-invasive DNA Prenatal Testing Market Share by Players (2018-2023)

Table 16. Global Top Non-invasive DNA Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive DNA Prenatal Testing as of 2022)

Table 17. Ranking of Global Top Non-invasive DNA Prenatal Testing Companies by Revenue (US$ Million) in 2022

Table 18. Global 5 Largest Players Market Share by Non-invasive DNA Prenatal Testing Revenue (CR5 and HHI) & (2018-2023)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Non-invasive DNA Prenatal Testing Product Solution and Service

Table 21. Date of Enter into Non-invasive DNA Prenatal Testing Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-invasive DNA Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Type (2018-2023)

Table 25. Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Type (2024-2029)

Table 27. Global Non-invasive DNA Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Application (2018-2023)

Table 29. Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Application (2024-2029)

Table 31. North America Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 32. North America Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)

Table 33. North America Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)

Table 34. Europe Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 35. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)

Table 36. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)

Table 37. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 38. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2018-2023) & (US$ Million)

Table 39. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2024-2029) & (US$ Million)

Table 40. Latin America Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 41. Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)

Table 42. Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)

Table 43. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)

Table 45. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)

Table 46. Illumina Company Detail

Table 47. Illumina Business Overview

Table 48. Illumina Non-invasive DNA Prenatal Testing Product

Table 49. Illumina Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 50. Illumina Recent Development

Table 51. Roche Company Detail

Table 52. Roche Business Overview

Table 53. Roche Non-invasive DNA Prenatal Testing Product

Table 54. Roche Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Natera Company Detail

Table 57. Natera Business Overview

Table 58. Natera Non-invasive DNA Prenatal Testing Product

Table 59. Natera Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 60. Natera Recent Development

Table 61. Thermo Fisher Scientific Company Detail

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product

Table 64. Thermo Fisher Scientific Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 65. Thermo Fisher Scientific Recent Development

Table 66. F. Hoffman-La Roche Company Detail

Table 67. F. Hoffman-La Roche Business Overview

Table 68. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product

Table 69. F. Hoffman-La Roche Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 70. F. Hoffman-La Roche Recent Development

Table 71. Pacific Biosciences Of California Company Detail

Table 72. Pacific Biosciences Of California Business Overview

Table 73. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product

Table 74. Pacific Biosciences Of California Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 75. Pacific Biosciences Of California Recent Development

Table 76. Perkinelmer Company Detail

Table 77. Perkinelmer Business Overview

Table 78. Perkinelmer Non-invasive DNA Prenatal Testing Product

Table 79. Perkinelmer Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 80. Perkinelmer Recent Development

Table 81. LifeCodexx Company Detail

Table 82. LifeCodexx Business Overview

Table 83. LifeCodexx Non-invasive DNA Prenatal Testing Product

Table 84. LifeCodexx Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 85. LifeCodexx Recent Development

Table 86. Agilent Technologies Company Detail

Table 87. Agilent Technologies Business Overview

Table 88. Agilent Technologies Non-invasive DNA Prenatal Testing Product

Table 89. Agilent Technologies Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 90. Agilent Technologies Recent Development

Table 91. Labcorp Company Detail

Table 92. Labcorp Business Overview

Table 93. Labcorp Non-invasive DNA Prenatal Testing Product

Table 94. Labcorp Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 95. Labcorp Recent Development

Table 96. Mutiplicon Company Detail

Table 97. Mutiplicon Business Overview

Table 98. Mutiplicon Non-invasive DNA Prenatal Testing Product

Table 99. Mutiplicon Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 100. Mutiplicon Recent Development

Table 101. Premaitha Health Company Detail

Table 102. Premaitha Health Business Overview

Table 103. Premaitha Health Non-invasive DNA Prenatal Testing Product

Table 104. Premaitha Health Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 105. Premaitha Health Recent Development

Table 106. Beijing BGI Company Detail

Table 107. Beijing BGI Business Overview

Table 108. Beijing BGI Non-invasive DNA Prenatal Testing Product

Table 109. Beijing BGI Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 110. Beijing BGI Recent Development

Table 111. Berry Genomics Company Detail

Table 112. Berry Genomics Business Overview

Table 113. Berry Genomics Non-invasive DNA Prenatal Testing Product

Table 114. Berry Genomics Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 115. Berry Genomics Recent Development

Table 116. Darui Biological Company Detail

Table 117. Darui Biological Business Overview

Table 118. Darui Biological Non-invasive DNA Prenatal Testing Product

Table 119. Darui Biological Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023) & (US$ Million)

Table 120. Darui Biological Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-invasive DNA Prenatal Testing Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Non-invasive DNA Prenatal Testing Market Share by Type: 2022 VS 2029

Figure 3. Equipment Features

Figure 4. Consumables Features

Figure 5. Global Non-invasive DNA Prenatal Testing Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 6. Global Non-invasive DNA Prenatal Testing Market Share by Application: 2022 VS 2029

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Other Case Studies

Figure 10. Non-invasive DNA Prenatal Testing Report Years Considered

Figure 11. Global Non-invasive DNA Prenatal Testing Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Non-invasive DNA Prenatal Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Non-invasive DNA Prenatal Testing Market Share by Region: 2022 VS 2029

Figure 14. Global Non-invasive DNA Prenatal Testing Market Share by Players in 2022

Figure 15. Global Top Non-invasive DNA Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive DNA Prenatal Testing as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Non-invasive DNA Prenatal Testing Revenue in 2022

Figure 17. North America Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Non-invasive DNA Prenatal Testing Market Share by Country (2018-2029)

Figure 19. United States Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. Canada Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. Europe Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Europe Non-invasive DNA Prenatal Testing Market Share by Country (2018-2029)

Figure 23. Germany Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. France Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. U.K. Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. Italy Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Russia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Nordic Countries Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Asia-Pacific Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Asia-Pacific Non-invasive DNA Prenatal Testing Market Share by Region (2018-2029)

Figure 31. China Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Japan Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. South Korea Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Southeast Asia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. India Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Australia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Latin America Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Latin America Non-invasive DNA Prenatal Testing Market Share by Country (2018-2029)

Figure 39. Mexico Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Brazil Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Middle East & Africa Non-invasive DNA Prenatal Testing Market Share by Country (2018-2029)

Figure 43. Turkey Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Saudi Arabia Non-invasive DNA Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Illumina Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 46. Roche Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 47. Natera Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 49. F. Hoffman-La Roche Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 50. Pacific Biosciences Of California Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 51. Perkinelmer Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 52. LifeCodexx Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 53. Agilent Technologies Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 54. Labcorp Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 55. Mutiplicon Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 56. Premaitha Health Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 57. Beijing BGI Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 58. Berry Genomics Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 59. Darui Biological Revenue Growth Rate in Non-invasive DNA Prenatal Testing Business (2018-2023)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Non-invasive DNA Prenatal Testing Market Research Report 2023

Published Date: August 2023

Report Code: QYRE-Auto-15M15093

Global Non-invasive DNA Prenatal Testing Market Research Report 2023

FEATURED COMPANIES

Non-invasive DNA Prenatal Testing Market Size

Non-invasive DNA Prenatal Testing Market

Report Scope

Scope of Non-invasive DNA Prenatal Testing Market Report

FAQ for this report

How fast is Non-invasive DNA Prenatal Testing Market market growing?

What is the Non-invasive DNA Prenatal Testing Market market size in 2029?

FEATURED COMPANIES